CRANBURY, N.J., June 4, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment ...
DUBLIN, Ireland--(BUSINESS WIRE)--Sept. 22, 2006--Research and Markets (http://www.researchandmarkets.com/reports/c42471) has announced the addition of the new report ...
CRANBURY, N.J., Sept. 23, 2016 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results